semaglutide gallstones risk isn’t just a “weight-loss shot” — know the REAL benefits, risks & red flags before you prescribe or use it., Semaglutide is transforming diabetes and obesity care — but it’s not risk-free. GLP-1s & Gallbladder: What to

Industry forecasts project the market to exceed $100 billion by 2029, driven by expanded therapeutic indications and the anticipated launch of oral formulations

GLP-1 stands for glucagon-like peptide-1 , a hormone that plays a key role in regulating blood sugar and appetite

(PDF) Pizzagalli, D.A.*, Webb, C.A.*, Dillon, D.G., Tenke, C.E., Kayser, J., Goer, F., Fava, M., McGrath, P., Weissman, M., Parsey, R., Adams, P., Trombello, J., Cooper, C., Deldin, P., Oquendo, M.A., McInnis, M.G., Carmody, T., Bruder, G., Trivedi, M.H

Similar declines were observed for ADM (brand name Ozempic), AOM (brand name Wegovy), and unknown semaglutide

In the global market, Novo Nordisk is leading the way with its injectable drugs Wegovy and Ozempic, along with Rybelsus, the world's first oral semaglutide

If youre in this kind of situation, you may already be familiar with GLP-1 antagonists